主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
URGN
#2067
UroGen Pharma Ltd. Ordinary Shares
21.700
0
+4.28%
版块:
基础:
利润货币:
日范围
年范围
日变化
+4.28%
每月变动
-0.60%
6个月变化
+14.21%
年变化
+14.21%
前一天收盘价
20.810
0
Open
21.700
0
Bid
Ask
Low
21.700
0
High
21.700
0
交易量
74
市场
股票
医疗保健
URGN
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
42.2 M
46.09 M
46.11 M
46.26 M
46.81 M
—
Valuation ratios
Enterprise value
411.02 M
318.92 M
405.92 M
540.91 M
843.8 M
2.11 B
Price to earnings ratio
3.82
3.6
3.48
4.13
5.76
16.97
Price to sales ratio
4.97
5.05
5.2
6.71
9.83
26.8
Price to cash flow ratio
4.72
4.72
4.49
5.17
6.9
21.28
Price to book ratio
2.6
51.87
4.28
3.69
3.61
63.46
Enterprise value to EBITDA ratio
-4.94
-3.3
-3.76
-4.37
-6.29
-17.73
Profitability ratios
Return on assets %
-0.08
-0.13
-0.18
-0.24
-0.18
-0.73
Return on equity %
-0.93
-4.26
-0.94
-0.53
-0.29
-6.03
Return on invested capital %
-311.73
-364.1
-582.81
-642.29
-348.12
-1 937.33
Gross margin %
90.27
89.94
88.5
85.34
88.07
351.85
Operating margin %
-69.61
-112.59
-182.26
-171.17
-99.65
-565.66
EBITDA margin %
-69.22
-112.74
-182.83
-172
-100.68
-568.25
Net margin %
-93.93
-152.71
-216.47
-206.24
-121.34
-696.75
Liquidity ratios
Quick ratio
8.77
5.81
5.47
3.99
3.79
19.06
Current ratio
9
6.01
5.65
4.14
3.99
19.79
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.09
0.08
0.08
0.11
0.14
0.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.4
0.43
0.49
0.59
0.66
2.17
Long term debt to total equity ratio
4.77
-13.83
-2.63
-1.31
-1.06
-18.83
Per share metrics
Operating cash flow per share
-0.64
-0.29
-0.89
-0.83
-0.88
-2.89
EBIT per share
-0.41
-0.59
-0.78
-0.87
-0.58
-2.82
EBITDA per share
-0.4
-0.59
-0.78
-0.87
-0.58
-2.82
Total debt per share
—
—
—
—
—
—
Cash per share
5.9
5.14
4.23
3.39
2.65
15.4
Net current asset value per share
6.85
5.87
5
4.12
3.51
18.5
Tangible book value per share
0.59
-0.19
-0.98
-1.96
-2.4
-5.52
Working capital per share
6.09
4.89
4.12
3.13
2.63
14.77
Book value per share
0.59
-0.19
-0.98
-1.96
-2.4
-5.52
新闻
UroGen Pharma首席医疗官Schoenberg出售价值14.5万美元股份
UroGen Pharma CMO Schoenberg sells $145k in shares
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
2025 Performance Review And Future Strategy
UroGen Pharma股票创52周新高,达25.2美元
Urogen Pharma Ltd stock hits 52-week high at 25.2 USD
UroGen Pharma在古根海姆会议上:UGN-102上市的战略洞察
UroGen Pharma at Guggenheim Conference: Strategic Insights into UGN-102 Launch
Urogen Pharma股价创52周新高达23.66美元
Urogen Pharma stock hits 52-week high at 23.66 USD
UroGen Pharma Ltd. (URGN) Q3 2025 Earnings Call Transcript
UroGen Pharma股价在三期临床试验取得积极结果后大涨